Trials / Completed
CompletedNCT03210974
Retrospective Observational Study About Evolution of Patients With Breast Cancer in Hospitals From GEICAM Group
Retrospective Observational Study About the Evolution of Patients With Breast Cancer in Hospitals From the GEICAM Group (2002 - 2005). ALAMO IV
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 13,135 (actual)
- Sponsor
- Spanish Breast Cancer Research Group · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a non-interventional (NIS), multicenter, retrospective cohort study, which will obtain data from patients diagnosed with invasive breast cancer between 2002 and 2005 in the medical oncology departments of hospitals that are members of GEICAM (using information obtained from patient medical histories).
Detailed description
There is no specific treatment regimen for this study. This is an observational retrospective study in which the clinical decisions concerning the optimal strategy in the treatment of the disease for each patient have been taken independently and prior to the physician's decision to include patient data in this registry, in keeping with the drug information, local treatment guidelines and/or standard clinical practice. The study target population are all patients (men and women) who have been newly diagnosed with invasive breast cancer between January 1, 2002 and December 31, 2005 and treated in the medical oncology departments of participating sites, ensuring an approximate follow-up of 10 years.
Conditions
Timeline
- Start date
- 2016-06-03
- Primary completion
- 2021-03-01
- Completion
- 2021-03-01
- First posted
- 2017-07-07
- Last updated
- 2023-03-06
Locations
41 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT03210974. Inclusion in this directory is not an endorsement.